No Data
No Data
No Data
No Data
No Data
Siemens Healthineers AG Goes Ex Dividend Tomorrow
Seeking AlphaApr 18 10:54 ET
Siemens Healthcare joins hands with the CHESS Liver Health Alliance and the National Innovation Platform to jointly promote industry-university-research-medical innovation cooperation
The two sides plan to launch industry-university-research transformation cooperation in liver angiology technology and a team of academicians to jointly unveil the “Medical Engineering Cross-Innovation Workstation”. The scope of future cooperation will be further expanded to include the fields of accurate diagnosis and treatment of chronic liver disease, Hangzhou, April 15, 2024/PRNewswire/ -- Recently, empowered by Southeast University's National Medical Research, Obstetrics and Education Integration Innovation Platform, CHESS Liver Health Alliance and Siemens Healthcare will jointly unveil the “Medical Engineering Cross-Innovation Workstation”.” The “Medical Engineering Cross-Innovation Workstation” will be launched at Siemens Healthcare's Shanghai Innovation Center. The preliminary plans of the two sides revolve around the subject of chronic liver disease
PR NewswireApr 15 04:30 ET
Siemens Healthineers Commit to Increase Localization in China
Germany-based Siemens Healthineers pledged to deepen localization in China with an increasing number of localized products and the continuous localization of its supply chain as they have noticed the capability of independent innovation from the country, said the company's top executive for China.
China DailyApr 11 02:07 ET
Investing in Siemens Healthineers (ETR:SHL) Five Years Ago Would Have Delivered You a 57% Gain
Yahoo FinanceApr 11 00:49 ET
SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS To Go Ex-Dividend On April 19th, 2024 With 0.51638 USD Dividend Per Share
March 27th - $SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS(SMMNY.US)$ is trading ex-dividend on April 19th, 2024. Shareholders of record on April 22nd, 2024 will receive 0.51638 USD di
moomoo NewsMar 26 20:50 ET
Siemens Healthcare grew strongly in the first quarter, laying a solid foundation for the 2024 fiscal year
ERLANGEN, Germany, Feb. 1, 2024/PRNewswire/ -- Siemens Healthcare today released its results report for the first quarter of the 2024 fiscal year ending December 31, 2023. The equipment order shipment ratio in the first quarter of FY2024 was as high as 1.14, excluding the rapid COVID-19 antigen testing business, which was a strong increase of 7.0%; taking into account the rapid COVID-19 antigen testing business that had been terminated in the fourth quarter of FY2023, comparable revenue increased 5.7%, and the imaging business increased 5.3% compared to revenue; due to the adverse effects of the short-term business portfolio, adjusted profit before interest and tax
PR NewswireFeb 1 03:30 ET
No Data
No Data